ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of care"

  • Abstract Number: 1982 • ACR Convergence 2025

    Bridging the Gap in Underserved Care: A Quality Improvement Initiative to Increase Pneumococcal Vaccination Rates in Immunocompromised Rheumatology Patients

    Kuan-Tung Lin1, Yue Hao2, Mai Abdelnabi2 and Wai-Hang Jackie Lam2, 1North East Medical Services, San Mateo, CA, 2North East Medical Services, San Francisco, CA

    Background/Purpose: Patients with rheumatologic conditions who are on immunosuppressive therapy face an elevated risk of pneumococcal infections, particularly those in medically underserved populations. Per ACR…
  • Abstract Number: 1050 • ACR Convergence 2025

    Bridging the Gap: A Mixed-Methods Study to Enhance Integration of HCQ-SAFE, A Shared Decision-Making Tool for Hydroxychloroquine Use, in Routine Lupus Care

    Isabella Hartel1, Jay Patel1, David Gazeley2, Drake Johnson1, Justin Levinson1, Carmen Campbell1, Britney Youngchild3, Shelby Gomez3, Amannda Weber4, Jessica Michaud5, Laura Dickmann6, Sancia Ferguson7, Betty Chewning8, Christie Bartels9 and Shivani Garg10, 1University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3University of Wisconsin, School of Pharmacy, Madison, WI, 4University of Wisconsin (UW), UW Health, Madison, WI, 5Medical College of Wisconsin, Milwaukee, Madison, WI, 6Medical College of Wisconsin, Milwaukee, Milwaukee, 7University of Wisconsin School of Medicine and Public Health, Madison, Madison, WI, 8University of Wisconsin, School of Pharmacy, Madison, 9University of Wisconsin School of Medicine and Public Health, Madison, WI, 10University of Madison, School of Medicine and Public Health, Madison, WI

    Background/Purpose: Hydroxychloroquine (HCQ) is a key therapy for lupus (or SLE). Yet, challenged to weigh benefits vs. harms, ~80% of patients self-discontinue HCQ. Shared decision-making…
  • Abstract Number: 0218 • ACR Convergence 2025

    Creating an EHR Lupus Outreach Workbench to Address Care Gaps

    Ross Gilbert1, Starla Blanks2, Joy Buie3, Mary Cronin4, Jake Decker5, Laura Dickmann6, Cristina Drenkard7, Sancia Ferguson8, Shivani Garg9, David Gazeley5, Andrea Gilmore-Bykovskyi10, Gale Johnson11, Patti Katz12, Tristan Lazewski13, S. Sam Lim14, Jenna McGoldrick15, Katrina Phelps10, Edmond Ramly16, Rosalind Ramsey-Goldman17, Ann Rosenthal18, Dawn Thomas-Semanko19, Sarah Stoltz13, Patricia Tellez-giron20, Amannda Weber21, Andrea Wipperfurth13 and Christie Bartels10, 1Johns Hopkins University, Baltimore, MD, 2American College of Rheumatology, Atlanta, GA, 3Lupus Foundation of America, Washington, DC, 4retired, Fox Point, WI, 5Medical College of Wisconsin, Milwaukee, WI, 6Froedtert Health, Waukesha, WI, 7Rollins School of Public Health, Emory University, Atlanta, Georgia, USA, Acworth, GA, 8University of Wisconsin School of Medicine and Public Health, Madison, Madison, WI, 9University of Madison, School of Medicine and Public Health, Madison, WI, 10University of Wisconsin School of Medicine and Public Health, Madison, WI, 11Wisconsin Department of Health Services, Madison, WI, 12UCSF, San Rafael, CA, 13UW Health, Madison, WI, 14Emory University School of Medicine, Atlanta, GA, 15SSM Health, Madison, WI, 16Indiana University - Bloomington, Bloomington, IN, 17Northwestern University Feinberg School of Medicine, Chicago, IL, 18Department of Medicine, Division of Rheumatology, Medical College of Wisconsin, Wisconsin, 19WI Chapter - LFA, Milwaukee, WI, 20University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 21University of Wisconsin (UW), UW Health, Madison, WI

    Background/Purpose: Lupus affects up to 1.5 million people in the US with significant health disparities in care and outcomes that call for care delivery innovation.…
  • Abstract Number: 1981 • ACR Convergence 2025

    High Patient Satisfaction with a Medication Education Program: Program to Understand Rheumatology Medications with Pharmacist Led Education

    Kami Roake1, Natalie Morlan1, Stephanie Lim1, Jennifer Giles1, Anthony Minjarez2, Grant Cannon3, Nadia Grant4, Vivianne Allsop5, Miranda Jensen1, Madeline O'Sullivan1, Christopher Ching1, Michael Bessen1, Javier Rios6 and Jessica A. Walsh7, 1University of Utah, Salt Lake City, UT, 2Salt Lake City VA, Salt Lake City, UT, 3University of Utah and Salt Lake City VA, Salt Lake City, UT, 4University of Utah, Salt Lake City, 5University of Utah, South Jordan, UT, 6University of Utah Health, Salt Lake City, UT, 7Division of Rheumatology, Salt Lake City Veterans Affairs Health and University of Utah Health, Salt Lake City, UT

    Background/Purpose: Patient education is critical for managing rheumatic diseases. Rheumatology clinic pharmacists are well-positioned to assess and address gaps in patients’ understanding of their medications.…
  • Abstract Number: 1040 • ACR Convergence 2025

    Impact of Clinical Pharmacist-Directed Patient Education on Medication Adherence and Clinical Outcomes in Patients with Inflammatory Arthritis

    Cristina Hurley1, Megha Kotha2, Jisna Paul3 and Jeff Barbee4, 1Carilion Clinic, Roanoke, VA, 2Ohio State University, Columbus, OH, 3Division of Rheumatology and Immunology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, Columbus, OH, 4Ohio State University Wexner Medical Center, Columbus

    Background/Purpose: This study assesses the impact of a clinical pharmacist-directed intervention on medication adherence and clinical outcomes in patients with rheumatoid arthritis, psoriatic arthritis, and…
  • Abstract Number: 0211 • ACR Convergence 2025

    Initial Results From a Single-Center Quality Improvement Initiative Using the Shingrix Rheumatology Immunization Dashboard Within the Veterans Health Administration

    Alexandra Do1, Lisa Matsumoto1, Cherish Wilson2, Gary Tarasovsky3, gabriela Schmajuk4 and Jennifer Barton5, 1Oregon Health and Science University, Portland, 2UCSF / SFVA, San Francisco, CA, 3UCSF, San Francisco, 4University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, CA, 5VA Portland Health Care System/OHSU, Portland, OR

    Background/Purpose: Disease-modifying antirheumatic drugs (DMARDs) are used to treat many rheumatologic diseases by modulating the patient’s immune system. However, patients on DMARDs are more susceptible…
  • Abstract Number: 2620 • ACR Convergence 2025

    Transition Success of Pediatric Rheumatology Patients: A Novel Scoring System

    Kyla Blasingame1, David McDonald1, Karissa Chesky1, Jimin Kim1, charles lee1, Constance Wiemann1, Blanca Sanchez-Fournier1, Miriah Gillispie-Taylor2 and Tiphanie Vogel1, 1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine/Texas Children's Hospital, Houston, TX

    Background/Purpose: Success of transition from pediatric to adult care depends on many factors. Various scores for transition readiness have been developed, including some designed to…
  • Abstract Number: 1972 • ACR Convergence 2025

    Enhancing Patient Safety: Improving Contraceptive Counseling for Patients on Teratogenic Medications in the Rheumatology Clinic

    Abimbola Fadairo-Azinge1, jobelle Romulo2, Daniella Flores3, jose Giron2, Joshua Ng4, Sarah Patterson5, Jinoos Yazdany6 and Andrew Gross6, 1UCSF, San Francisco, 2University of California San Francisco, San Francisco, 3University of California San Francisco, San Francisco, CA, 4University of California San Francisco, SAN-FRANCISCO, CA, 5University of California, San Francisco, Pacifica, CA, 6UCSF, San Francisco, CA

    Background/Purpose: The American College of Rheumatology (ACR) recommends contraceptive counseling for reproductive-age women with rheumatic and musculoskeletal diseases (RMDs), especially those on teratogenic medications. These…
  • Abstract Number: 0606 • ACR Convergence 2025

    Increased Recombinant Zoster Vaccination in SLE following Public Reimbursement: Data from Two Prospective SLE Cohorts

    Arielle Mendel1, Nathalie Amiable2, Yvan St-Pierre3, Sasha Bernatsky4, Ines Colmegna5, Michaël Desjardins6, Louis-Pierre Grenier7, Fares Kalache8, Christian Pineau9, Chantal Sauvageau10, Evelyne Vinet4 and Paul Fortin11, 1McGill University Health Centre, Montréal, QC, Canada, 2Centre de recherche du CHU de Québec – Université Laval, Quebec City, QC, Canada, 3Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 4Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 5The Research Institute of the McGill University Health Centre, Montréal, QC, Canada, 6Centre Hospitalier de l'Université de Montréal (CHUM)), Montreal, QC, Canada, 7Montreal General Hospital, Montréal, QC, Canada, 8McGill University Health Center, Montreal, QC, Canada, 9McGill University, Montréal, QC, Canada, 10Institut national de santé publique du Québec, Quebec City, QC, Canada, 11Centre ARThrite - CHU de Québec - Université Laval, Quebec, QC, Canada

    Background/Purpose: Herpes Zoster (shingles) is a common preventable adverse event in SLE. In Quebec, Canada, the Recombinant Zoster Vaccine (RZV) became free of charge for…
  • Abstract Number: 0210 • ACR Convergence 2025

    Improving Recombinant Zoster Vaccine Uptake in Younger Adults with Rheumatoid Arthritis through a Partnership with Specialty Pharmacy

    Akhil Sood1, Srijana Davuluri2, Sheila Haidar3, De Suan Huang3, April Ochoa3, Christy Bill1 and Janice Lin1, 1Stanford University, Palo Alto, CA, 2Stanford University, Stanford, CA, 3Stanford Health Care, Palo Alto, CA

    Background/Purpose: Despite guideline recommendations, recombinant zoster vaccine (RZV) uptake remains low among immunocompromised individuals younger than 50 years of age, notably those with rheumatoid arthritis…
  • Abstract Number: 2619 • ACR Convergence 2025

    What Works? A Consolidated Framework for Implementation Research-Guided Exploration of Patient Safety in Rheumatology Practices

    Catherine Nasrallah1, Cherish Wilson2, Christine Hariz3, Alicia Hamblin4, Cammie Young5, gabriela Schmajuk6 and Jinoos Yazdany4, 1University of California San Francisco (UCSF), San Francisco, CA, 2UCSF / SFVA, San Francisco, CA, 3University of California San Francisco (UCSF, San Francisco, CA, 4UCSF, San Francisco, CA, 5University of California, San Francisco, Oakland, CA, 6University of California, San Francisco, and San Francisco Veterans Affairs Medical Center, San Francisco, CA

    Background/Purpose: Despite widespread recognition of persistent patient safety challenges in the U.S. health care system, the development of feasible and scalable solutions has lagged, particularly…
  • Abstract Number: 1928 • ACR Convergence 2025

    Oral Health in Patients with Rheumatic Diseases: A Pilot Quality Improvement Program

    Margarita Isabel Alarcon-Jarquin1, Fernanda M. Garcia-Garcia2, Vanessa L. Lopez-Flores1, Aleydis Gonzalez-Melendez3, Gabriel Figueroa-Parra3, Dionicio A. Galarza-Delgado2 and Janett C. Riega-Torres4, 1Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 3Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico

    Background/Purpose: Patients with rheumatic diseases commonly experience oral health issues such as dental caries, xerostomia, and periodontal disease. These complications are linked to both the…
  • Abstract Number: 0826 • ACR Convergence 2025

    Impact of Large Language Models on Diagnostic Reasoning of Medical Students in Rheumatology: A Randomized Trial

    Anna Roemer1, Nadine Schlicker2, Anna Kernder3, Benedikt Albe1, Juliana Hack4, Martin Hirsch5, Sebastian Kuhn1 and Johannes Knitza6, 1Institute for Digital Medicine, University Hospital of Giessen and Marburg, Philipps University Marburg, Marburg, Germany, 2Institute for Artificial Intelligence in Medicine, University Hospital Giessen and Marburg, Marburg, Germany, 3Department of Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, 4Center for Orthopaedics and Trauma Surgery, University Hospital Giessen and Marburg, Marburg, Germany, 5Institute for Artificial Intelligence in Medicine, University Hospital Giessen and Marburg, Philipps University Marburg, Marburg, Germany, 6Institute for Digital Medicine, University Hospital Gießen-Marburg, Philipps University, Marburg, Germany

    Background/Purpose: Although not certified as medical devices, Large Language Models (LLMs) such as ChatGPT-4 provide rapid support in diagnostic reasoning and may facilitate scalable upskilling…
  • Abstract Number: 0191 • ACR Convergence 2025

    Advanced therapy use in RA patients with moderate disease activity in a large NHS Foundation Trust in South London, UK

    Aoibhinn Kelly1, Maddalena Rupnik2, Nasra Ahmed1, Mrinalini Dey3 and Elena Nikiphorou4, 1King's College Hospital NHS Foundation Trust, London, United Kingdom, 2Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 3Centre for Rheumatic Diseases, King's College London, London, United Kingdom, 4King's College London, London, United Kingdom

    Background/Purpose: Moderate disease in rheumatoid arthritis (RA) is defined as a 28-joint disease activity score (DAS28) of 3.2-5.1(MDAS). As per the National Institute for Health…
  • Abstract Number: 2616 • ACR Convergence 2025

    Real-World Implication of Clinical Disease Activity Index (CDAI) Utilization on Treatment Decisions and Clinical Outcomes in Rheumatoid Arthritis

    Ryan Clark1, Sally Almahdawi1, Carolina Alvarez2, Rumey Ishizawar3 and Thuyvan Phan4, 1UNC Eshelman School of Pharmacy, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Miami, FL, 3UNC Division of Rheumatology, Allergy and Immunology and TARC, Chapel Hill, NC, 4UNC Health, Chapel Hill, NC

    Background/Purpose: The University of North Carolina (UNC) Hospitals Rheumatology Clinic is utilizing the Clinical Disease Activity Index (CDAI) in patients with rheumatoid arthritis (RA) per…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 24
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology